LMAT - LeMaitre Corp Growth-Adjusted Payback Ratio

Corporate company logo of lemaitre.com (LMAT)

The implementation of ESG environmental standards and packaging optimization are driving the growth of LeMaitre Vascular, Inc. (LMAT). The PEG ratio history illustrates current dynamics, where the value of 2.26 represents the most recent figure. Business stability relies on surgeon trust and device certification, while a strategy of targeted M&A transactions enables the rapid integration of new niche technologies into the global sales network.

LeMaitre Corp (LMAT): Price/Earnings to Growth Ratio from 07/04/2022 to 11/13/2026

LeMaitre Vascular, Inc. (LMAT) - metric breakdowns and financial figures

- current price and projected stock value:
- market capitalization statistics:
Fundamental company analysis:LeMaitre Vascular Inc, LMAT
Core merchandise of LeMaitre Corp

To protect capital during periods of volatility, it is crucial for investors to correlate business value with profit dynamics, which is achieved by dividing the P/E multiple by growth rates. By analyzing the growth-adjusted P/E, one can identify asset undervaluation, which in the case of LeMaitre Vascular, Inc. (LMAT) is supported by high plant efficiency and the automation of vascular surgery product manufacturing.

Who LeMaitre Vascular, Inc. competes with

Price/Earnings to Growth Ratio ISRG (Intuitive Surgical, Inc.)|Danaher Corp - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio BDX|STERIS plc - PEG Multiple|Growth-Adjusted Market Cap to Net Income westpharma.com WST|Baxter (BAX) - Price/Earnings to Growth Ratio|Growth-Adjusted P/E Ratio MASI|Price/Earnings to Growth Ratio Stevanato|Teleflex Corp (TFX) - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Multiple MMSI (Merit Medical Systems)|Company Value to Earnings Growth Ratio NVST|Price/Earnings to Growth Ratio ICU Medical ICUI|Growth-Adjusted Payback Ratio XRAY|ATRC: Price/Earnings to Growth Multiple|STAA - PEG Multiple|niagenbioscience.com (NAGE) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple zimvie.com|ANGO (AngioDynamics) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Cerus Corp. CERS|Price/Earnings to Growth Ratio Alpha Teknova Inc (TKNO)|Monogram Orthopedics Inc. - Growth-Adjusted P/E Ratio|Sharps Technology - Price/Earnings to Growth Multiple|Company Value to Earnings Growth Ratio INFU (InfuSystem)|UTMD - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income KORU Medical Systems KRMD|Nyxoah, S.A. (NYXH) - Price/Earnings to Growth Ratio|MBOT (Microbot Medical, Inc) - Price/Earnings to Growth Ratio|PDEX (Pro-Dex, Inc.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate zentek.com ZTEK|Price/Earnings to Growth Ratio Elutia (ELUT)|Price/Earnings to Growth Multiple Milestone Scientific Inc MLSS|PEG Multiple NXGL (NEXGEL, Inc)|PEG Multiple Retractable Technologies Inc. RVP|Harvard Bioscience, Inc. - PEG Multiple|Growth-Adjusted Market Cap to Net Income femasys.com FEMY|MHUA (meihuamed.com) - Price/Earnings to Growth Multiple|POAI: Company Value to Earnings Growth Ratio|Price/Earnings to Growth Ratio Callan JMB Inc.|ATRI: Growth-Adjusted Payback Ratio|PEG Multiple NURO